Here is the list of the laureates from 1994 to today


Year

Prix Galien Research

Prix Galien Innovative Product

2022

N/A

Takhzyro (lanedelumab injection) Takeda Canada Inc.

Year

Prix Galien COVID-19 Award

Prix Galien Innovative Product

2020

MEDICAGOPatisiran (ONPATTRO) Alnylam Pharmaceuticals
Year Prix Galien Research Prix Galien Innovative Product
2019
 DR. SUSAN GEORGE, DR. BRIAN O'DOWD, DR. GREGORY A. DEMOPULOS, DR. GEORGE A. GAITANARIS, DR. ALEXANDER GRAGEROV

SHINGRIX (Recombinant Zoster Vaccine) GSK

2018N/ASACUBITRIL/VALSARTAN (Entresto) Novartis Pharmaceuticals Canada Inc.
 2017
DR. ERNESTO SCHIFFRIN (McGill University)
KEYTRUDA (pembrolizumab) Merck Canada
2016DR. PHILIP F. HALLORAN OC, MD, PhD, FRCPC, FRSCHARVONI (Sofosbuvir/Ledipasvir) Gilead Sciences Canada
ENTYVIO (Vedolizumab) Takeda Canada
2015DR. JOHN KELTON, DR. THEODORE WARKENTIN
afatinib (Giotrif) (Boehringer-Ingelheim Canada)
2014DR. BRETT FINLAY (University of British Columbia)
PIRFENIDONE (ESBRIET) InterMune Canada (Roche))
2013DR. FRANCIS ALLAN PLUMMER (University of Manitoba)(YERVOY) IPILIMUMAB (Bristol Myers Squibb Canada)

2012

DR. ROBERT E. W. HANCOCK (University of British Columbia)

INCIVEK (TELAPREVIR) (Vertex Canada Ltd) 

VICTRELIS (BOCEPRIVIR) (Merck Canada Inc.)

2011

DR. PIETER R. CULLIS (University of British Columbia)

PRADAX (Boehringer Ingelheim Canada)

2010

DR. JULIO S. G. MONTANER (BC Center for Excellence in HIV/AIDS)

STELARA (Janssen-Ortho)

2009 DR. DONALD F. WEAVER (University of Dalhousie) CHAMPIX  (Pfizer Canada inc.)
2008 DR. DANIEL J. DRUCKER (University of Toronto) GARDASIL (Merck Frosst Canada)
2007 DR. MICHAEL HAYDEN (University of British Columbia)

2006 DR. HAROLD JENNINGS (National Research Council Canada)

2005 DR. LORNE BABIUK (University of Sakatchewan)  

2004 DR. PAUL ARMSTRONG (Faculty of medecine, University of Alberta) SPIRIVA (Boehringer Ingelheim Canada)
2003 DR. MARK A. WAINBERG (Jewish General Hospital – Sir Mortimer B. Davis) GLEEVEC (Novartis Pharma Canada)
2002 DRS. JULIA LEVEY et DAVID DOLPHIN (University of British Columbia ) and (ex aequo) DR ANTONY J. PAWSON (University of Toronto ) ENBREL (Wyeth-Ayerst Canada)
2001 DR. SALIM YUSUF (Research Centre of the Hamilton Civic Hospital) VIAGRA (Pfizer)
2000 MONTELUKAST SODIUM RESEARCH TEAM SUR LE  (Merck Frosst) SINGULAIR (Merck Frosst)
1999 DR. JACK HIRSH (Research Centre of the Hamilton Civic Hospital ) LIPITOR (Parke-Davis Canada)
1998 DRS. LORNE TYRRELL and MORRIS ROBIN (University ofEdmonton Alberta) FOSAMAX (Merck Frosst Canada)
1997 DRS. SERGE GAUTHIER, JUDES POIRIER et RÉMI QUIRION (McGill University and Research Centre of the Douglas Hospital ) 3TC (découvert par BioChem Pharma et développé par Glaxo Wellcome)
1996 ANTIVIRAL COMPOUNDS RESEARCH TEAM (BioChem Pharma) SABRIL (Marion Merrell Dow)
1995 DR. PETER SCHILLER (IRCM) RISPERDAL (Janssen Pharmaceutical)
1994

DRS. PHILIP SEEMAN, HYMAN NIZNIK et HUBERT VAN TOL (University of Toronto)

IMMITREX (Glaxo Canada)